Publication | Open Access

Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyClinical TrialsRandomised Phase 2Myeloid NeoplasiaAcute Myeloid LeukaemiaTreatment OptionPharmacotherapyOncologyRadiation OncologyOlder PatientsHealth Sciences